Anyone familiar with the pharmaceutical industry could tell Valeant wasn't headed anywhere but down.

Just take a look at their portfolio of drugs. There is nothing special there. For the most part they were selling brand names drugs in diseases where a generic drug would work just fine. The only reason they made money is because they used every trick in the book to make sure nobody noticed what they were doing.

The company was bound to fail at some point in time.